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Abstract
Background: In Ethiopia, there is lack of data on the prevalence of hepatitis B virus (HBV), hepatitis C virus (HCV)
and human immune deficiency virus (HIV) infections in adult population at community level. This study aimed at
determining the HBV, HCV and HIV seroprevalence in adult population at community level in East and West Gojjam
zones in Amhara region, Ethiopia.
Methods: A cross-sectional study was conducted between October 01 and November 30, 2015. The Hepatitis B
surface antigen (HBsAg) and anti-HCV were detected using the standard serological tests. The antibody to HIV
infection was tested using the national HIV rapid tests algorithms.
Results: A total of 481 adults comprised of 51% females with median age of 25 years took part in the study. Overall, 7.
5% (95% CI: 5.5–10.2%) of adult population were infected either with HBV, HCV and HIV. The prevalence of HBV was 15
(3.1%) and for HIV was 16 (3.3%). The seroprevalence of HCV was five (1.0%). HIV-HCV co-infection was found to be two
(0.4%). HIV prevalence was higher in non-educated population than their counter parts (P = 0.001). HIV prevalence was
high in housewives (6.0%) and merchants (4.7%).
Conclusions: This study revealed an intermediate HBV prevalence and low prevalence of HCV in adult population at
community level. HIV prevalence is still a major public health problem in the area. To have the national data, we
recommend further study on genotypes of HBV and HCV including local risk factors for transmissions. Moreover,
health education on HBV, HCV and HIV transmission should be an intervention measure in the community.
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Backgrounds
Infection with HBV, HCV and HIV are still a major public
health problem worldwide, particularly in developing
countries [1]. HBV and HCV infections can cause both
acute and chronic liver disease, including cirrhosis and
hepatocellular carcinoma (HCC). Studies showed that
80% of HCC was caused by active replication of chronic
HBV and HCV infections [2, 3]. For instance, about
686, 000 people die every year due to complications of
HBV infection (cirrhosis and HCC) [4].
According to the World Health Organization (WHO)
report, 34 million people are HIV positive worldwide
[5]. In Ethiopia, the prevalence of HIV infection differs
significantly among regions and different population
groups. WHO estimated that 753,100 people are living
with HIV in Ethiopia [6, 7]. However, the national HIV
prevalence declined from 1.5 to 1.1% in 2015 [6, 7].
Urban populations are more affected with HIV than
rural areas while females are twice affected than male
population [6]. Globally, about 400 million and 170
million people are chronically infected with HBV and
HCV, respectively [8]. Approximately 1 million people die
each year from hepatitis B and C virus infections [9].
* Correspondence: bayeabera15@gmail.com
1Department of Microbiology, Immunology & Parasitology, College of
Medicine & Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Abera et al. Virology Journal  (2017) 14:21 
DOI 10.1186/s12985-017-0696-6
In Ethiopia, there is lack of information on the prevalence
of HBV, HCV and HIV in the general population. This is
due to the fact that virtually all prevalence data on HBV,
HCV and HIV have been obtained in selected group of
people with risk factors such as pregnant women, military
personnel and patients with liver disease [10–12]. For
instance, the prevalence of HBV and HCV in pregnant
women was between 4.4 and 0.26%, respectively [13].
Therefore, the prevalence of HBV, HCV and HIV infec-
tions at the community level is not known. The present
study was therefore conducted to determine the preva-
lence of HBV, HCV and HIV infections among adults at
house hold level in the community in East and West
Gojjam zones in Amhara region, Ethiopia.
Methods
Study design and period
We conducted a community-based cross sectional study
in East and West Gojjam administrative zones in Amhara
region between October 01 and November 30, 2015. From
each household, only one adult who gave consent to
participate in the study were involved in the study.
Source and study population
The source population was all apparently healthy adult
population in East and West Gojjam Zones in the Amhara
region. Apparently healthy adults with age ≥ 18 years of
both sexes from the selected households in the study area
were deemed a study population.
Sample size and sampling
The sample size was calculated using single population
proportion formula. It was calculated by taking a pro-
portion of 0.5 by assuming that the mean (μ) population
for each parameter is known to be 50%, 2% marginal
error, and 95% confidence levels. Therefore, the sample
size of 481 was determined. The households from each
district were selected using systematic random sampling
technique after getting the nth value by dividing the
total number of households with the total number of
selected households.
Data collection
Trained laboratory technicians interview study participants
and collected data on demographic, monthly income,
education and marital status were collected by face to
face interview using a structured questionnaire.
Detection of HBsAg and anti-HCV and anti-HIV
Trained laboratory technicians collected 5 ml of whole
blood aseptically from vein by puncture. The collected
blood was allowed to clot then serum was separated by
centrifugation at room temperature. Antibody to HIV infec-
tion was tested using the national HIV rapid diagnostic tests
algorithm. Initially, HIV infection was screened using KHB
(Bio-Engineering, Shanghai, Kehua). The HIV positive sam-
ples were re-tested with STAT PAK (Chembio diagnostic,
Newyork, USA). HIV positive serums which showed
discordant results between the first test (KHB) and the
second test (STAT PAK) were tested with Unigold (Trinity
Biotech Bray, Ireland) as tie breaker.
The presence of hepatitis B surface antigens (HBsAg) in
serum was detected using advanced quality One Step Rapid
Test per instructions of the manufacturer (Zhejiang Orient
Gene Biotech, Zhejiang, China). The anti-HCV antibody
was detected using One Step Rapid Test per instructions of
the manufacturer (Zhejiang Orient Gene Biotech, Zhejiang,
China). The samples found to be positive for HBV and
HCV had been re-tested in duplicate. The HIV positive
samples were re-tested with STAT PAK per the manufac-
turers’ instruction. To ensure the reliability and quality of
data, positive and negative control sera were run following
the manufacturer recommendations alongside the test kits.
Data analysis
Data was entered into Statistical Package for Social Science
(IBM Corp. Released 2011. IBM SPSS Statistic Armonk, NY:
IBM Corp). A categorical variable were tested using the
Chi-square tests. All statistical tests were two-tailed, and
the significance level was set at P < 0.05.
Ethical clearance
The Research Ethics Review Committee of the College
of Medicine and Health Sciences of Bahir Dar University
has approved the ethical clearance. Written consent was
obtained from each study participants to provide blood
for HBV, HCV and HIV determination for research pur-
pose. The study participants found to be positive for HBV,
HCV and HIV were reported to physicians and/or health
officers for treatment and counselling. Information ob-
tained at any course of the study was kept confidential.
Results
Socio-demographic profiles
A total of 481 adults comprised of 245 (51%) of females
and 236 (49%) males from the community participated
in the study. The median age of the study participants
was 25 years (ranged 18–60 years). Assessment of educa-
tion showed that 153 (31.8%) of the participants did not
have formal education. The majority (97.1%) of participants
were urban residents. Table 1 depicts the marital status,
monthly income and occupation of the study participants.
Prevalence of HBV, HCV and HIV infection
Overall, 7.5% (95% CI: 5.5–10.2%) of adult population at
the community were infected either with hepatitis B or
C viruses and HIV. Of these, HBV prevalence accounted
for 3.1%. The seroprevalence of HCV was 5 (1.0%). The
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prevalence of HIV was 3.3%. In this study, only two
(0.4%) adults were co-infected with HCV and HIV.
However, HBV and HIV co-infection was not found.
Table 2 illustrated the prevalence of HBV, HCV and HIV
infections.
Risk factor for HBV, HCV and HIV prevalence
In the present study, no statistical significant differences
were observed for HBV and HCV infections in terms of
age, sex, residence and marital status. However, HIV preva-
lence was in higher in females than males (P = 0.001). Fur-
thermore, HIV prevalence was higher in non-educated
population than their counter parts (P = 0.001) (Table 3).
Considering occupations of adults, HIV prevalence was
higher in merchants (4.7%) than others.
Discussion
This study showed the prevalence of HBV, HCV and
HIV infections among adult population at the community
level. Overall, 7.5% of the adult population was infected
either with hepatitis B or C viruses and HIV. This indi-
cated that HBV, HCV and HIV infections are the major
public health problems in Ethiopia. HIV prevalence in the
present study (3.3%) is higher than the national adult HIV
prevalence which is 1.1% [14]. Furthermore, HIV preva-
lence in females (5.2%) was higher than the national HIV
prevalence among females (1.4%) [3]. Like other reports,
the prevalence of HIV was significantly higher in females
than males (P = 0.001) [14–16].
In this study, a statistically significant association was
observed between HIV prevalence and educational levels.
HIV prevalence was higher among non-educated adults
(P = 0.001). Likewise, studies indicated that HIV preva-
lence in developing countries was higher among less edu-
cated groups [8, 17]. It is well documented that in the
early stage of HIV pandemic, the prevalence of HIV infec-
tion was higher among well educated people in urban
areas than non-educated people. However, in later stage,
due to the availability of information on prevention of
HIV transmission, it decreases in educated people [17].
Furthermore, the prevalence of HIV was higher in mer-
chants. This conforms to a study conducted in Ethiopia
which stated that merchants had higher odds of being
HIV positive than others [18].
This study showed an intermediate (3.1%) prevalence
of HBV in adults at community level compared to 5–10%
HBV prevalence in adult population in sub-Saharan Africa
[9]. Likewise, a study conducted in Libya reported 2.2%
HBV prevalence in a general population [19]. In contrast,
it is lower compared to other studies conducted in various
part of Ethiopia. For instance, 3.8 to 4.4% of HBV preva-
lence was reported among pregnant women and military
person [10, 13, 20]. A statistically significant association
was not observed between HBV positive and risk factors.
Although, it was not statistically significant, adults with
low monthly income (<500 birr) had higher HBV preva-
lence (3.7 vs 1.9%) compared to those adults with better
income (P = 0.22).
Hepatitis C virus (HCV) prevalence in adult population
was low (1.0%). Similarly, low prevalence (0.6 to 0.7%) of
HCV was reported in pregnant women [11, 21]. In con-
trast, higher prevalence of HCV was documented among
attendants of voluntary counseling and testing for HIV in
Ethiopia. For instance, 9.1, 6.0 and 4.3% HCV prevalence
were reported in Hawassa, Mekelle and Adwa, respect-
ively [22–24]. This clearly showed that HCV in the gen-
eral population is low while higher in risk group of the
population.
People with HIV infection are often co-infected with
chronic viral hepatitis by HBV and HCV due to common
Table 1 Socio-demographic profiles of study participants for
HBV, HCV and HIV
Variables Number Percentage
Sex Female 245 51.0
Male 236 49.0
Age group 18–25 years 257 53.5
>26 years 224 46.5
Residence Urban 467 97.0
Rural 14 3.0
Education Elementary and above 351 73.0
No formal education 130 27.0




Monthly income <500 birr 324 67.4
≥500 birr 157 32.6






Table 2 Seroprevalence of HBV, HCV and HIV among adult
population
Variables Positive Negative Total
N (%) 95%, CI N (%)
HBsAg 15 (3.1) 1.9, 5.1 466 (96.9) 481 (100)
Ant-HCV antibody 5 (1.0) 0.4, 2.4 476 (99) 481 (100)
Anti-HIV antibody 16 (3.3) 2.1, 5.33 465 (96.3) 481 (100)
Co-infection (HIV&HCV) 2 (0.4) 0.1, 1.5 479 (87.5) 481 (100)
Total 36 (7.5) 5.5,10.2 445 (92.5) 481 (100)
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modes of transmission. Two (0.4%) adults were co-infected
by HCV and HIV. However, a study conducted on selected
risk group of people reported higher co-infection of
HIV-HBV (34%), HIV-HCV (8.0%) and HBV-HCV (2%)
[25]. Moreover, 5.6% HIV-HBV and 5% HIV-HCV co-
infections were documented in HIV positive individuals
[26]. These differences might be due to the study popu-
lation differences. The Quantative-real time polymerase
chain reaction (qRT-PCR) was not used to confirm the
positive samples. Therefore, this deemed to be a certain
limitation for this study.
Conclusion
This study showed an intermediate prevalence for HBV
and low for HCV in adult population at community level.
However, HIV prevalence was higher in non-educated
adults at community levels. We recommend further
national wide studies on the prevalence and genotypes
of HBV and HCV including risk factors in the general
population.
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Table 3 Association of HBV, HCV and HIV prevalence with sociodemogrphic variables
Variables HBsAg N (%) P- value HIV status N (%) P value HCV status N (%) P value
Pos Neg Pos Neg Pos Neg
Sex
Females 7 (3.0) 238 (97) 12 (5.0) 233 (95) 0.001 3 (1.2) 242 (98.8) NA
Males 8 (3.5) 228 (96.5) 0.92 4 (1.7) 232 (98.3) 2 (0.8) 233 (99.2)
Age group
18–25 years 8 (3.2) 249 (96.8) 0.93 8 (3.0) 249 (97.0) 2 (0.8) 255 (99.2) NA
≥26 years 7 (3.2) 217 (96.8) 8 (3.6) 216 (96.4) 0.48 3 (1.3) 221 (98.7)
Residence
Urban 14 (3.0) 453 (97) 0.62 15 (3.2) 452 (96.8) 5 (1.1) 462 (98.9)
Rural 1 (7.7) 13 (92.3) 1 (8.2) 12 (92.8) NA – 13 (100) NA
Marital status
Single 8 (3.4) 237 (96.6) 8 (3.2) 237 (96.8) 2 (0.8) 243 (99.2)
Married 6 (3.5) 183 (96.5) 0.95 6 (3.1) 183 (96.9) NA 3 (1.6) 186 (98.4)
Widowed – 20 (100) NA - 20 (100) – 20 (100) NA
Divorced 1 (3.8) 26 (96.2) NA 2 (7.4) 25 (92.6) – 27 (100)
Education
Elementary and above 12 (3.4) 339 (96.6) 0.28 6 (1.7) 345 (98.3) 0.001 3 (0.8) 348 (99.2)
No formal education 3 (2.3) 126 (97.7) 10 (7.8) 119 (92.2) 2 (1.6) 127 (98.4) NA
Monthly income
<500 birr 12 (3.7) 312 (96.3) 0.22 14 (4.3) 310 (95.7) 0.08 4 (1.2) 320 (98.8) NA
≥500 birr 3 (1.9) 154 2 (1.3) 155 (98.7) 1 (0.6) 156 (99.4)
Occupation
Government employee 3 (2.8) 102 (97.2) NA 3 (2.8) 102 (97.2) NA – 105 (100)
Merchant 2 (3.1) 62 (96.9) 3 (4.7) 61 (95.3) 1 (1.6) 63 (98.4) NA
Housewife 3 (3.5) 82 (97.2) 5 (6.0) 80 (94.0) 1 (1.2) 84 (98.8)
Farmer 1 (2.8) 34 (97.2) – 35 (100) – 35 (100)
Non-employee 6 (3.1) 185 (96.9) 5 (2.6) 186 (97.4) 3 (1.6) 188 (98.4)
NA: not applicable
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